← Leaderboards
Yevgeniy R Semenov
Massachusetts General Hospital
$528,120
Attributed
$528,120
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $176K · FY2023–25$200K$150K$100K$50K$0
'23
'24
'25
Funding mix
By agency
NIH$528,120 · 1
By mechanism
K23$528,120 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Tayyaba Hasan$21,611,486
- Khalid A Shah$15,720,802
- Bruce Fischl$45,281,925
- Douglas Nowlin Greve$3,454,968
- Richard T D'aquila$62,924,506
Others in their field
Other Rising Stars on “Epidemiology”
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- David Annett · Information Management Services, Inc.$17,500,000
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- James Cappo · National Jewish Health$9,298,220
- April Carson · University Of Mississippi Med Ctr$9,022,104
- Cathryn Peltz · Henry Ford Health + Michigan State University Health Sciences$7,977,678
Research focus
EpidemiologyAdverse EventAntigenic VariationAdverse ReactionsAutoimmune DiseasesAllelesAutoimmunityBig DataCancer TherapyAntitumor EffectCase StudyCheckpoint TherapyClinical DataClinical Decision SupportClinical DevelopmentClinically RelevantClinical RiskClinical TrialsCutaneousDana-Farber Cancer InstituteDermatologicDisease SusceptibilityEligibility DeterminationEtiology
Grant awards (3)
Predictive modeling of cutaneous immune checkpoint inhibitor toxicities$176,040
K23 · FY2025 · AR · contact PI
Predictive modeling of cutaneous immune checkpoint inhibitor toxicities$176,040
K23 · FY2024 · AR · contact PI
Predictive modeling of cutaneous immune checkpoint inhibitor toxicities$176,040
K23 · FY2023 · AR · contact PI